FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321073130> ?p ?o ?g. }

• W4321073130 endingPage "147264" @default.
• W4321073130 startingPage "147264" @default.
• W4321073130 abstract "Calcium and oxalate are the most abundant metabolites present in the stone matrix. The SPP1 and UMOD gene has specific expression in kidneys and are involved in various stages of stone formation. Therefore, genetic variants in the SPP1 and UMOD genes may enhance the development of renal stone disease. This study has been designed to understand the association of genetic variants of SPP1 and UMOD genes with renal stone disease.A prospective study has been carried out, including 150 renal stone disease patients and 150 healthy individuals. Biochemical parameters were performed, including serum calcium levels, creatinine, parathyroid hormone, and 24-Hour urine metabolites. The genotyping of SPP1 (rs1126616) and UMOD (rs4293393) gene variants were performed using a customized TaqMan probe. T-test was used for continuous biochemical data analysis. The Chi-square test has been applied to assess the risk of a particular genotype associated with renal stone disease. In addition, correlation analysis for biochemical parameters and genetic variants with the renal stone disease has been performed using Shapley additive explanations (SHAP) values calculated with the help of the pycaret library.Renal stone patients had significantly higher levels of parathyroid hormone (93.37 ± 52.78 pg/ml vs 64.67 ± 31.50 pg/ml, P=<0.0001), serum creatinine (0.94 ± 0.38 mg/dl vs 0.77 ± 0.17 mg/dl, P=<0.0001) and 24hr urine metabolites in comparison to the healthy controls. Heterozygous (CT) variant of SPP1 and homozygous (GG) variant of UMOD genes were significantly associated with an increased risk of developing the renal stone disease (p = 0.0100, OR = 2.06, 95 %CI = 1.13-3.75; p=<0.0001, OR = 5.773, 95 % CI = 2.03-16.38, respectively). Individuals with hyperparathyroidism and CC (SPP1) and GG (UMOD) genotypes have a high risk (P = 0.0055, OR = 2.75, 95 %CI = 1.35-5.67; P = 0.0129, OR = 10.03, 95 %CI = 1.60-110.40, respectively) of developing a renal stone. In addition, individuals with hypercalciuria and TT genotype of SPP1 (P = 0.0112, OR = 2.92, 95 % CI = 1.33-6.35), AG genotype of UMOD (P=<0.0001, OR = 5.45, 95 %CI = 2.24-13.96) and GG genotype of UMOD (P=<0.0001, OR = 10.02, 95 %CI = 3.53-24.63) have high risk of developing renal stones. Moreover, Individuals with hyperoxaluria and AG + GG (UMOD) genotype have a greater risk (P=<0.0001, OR = 7.35, 95 % CI = 3.83-13.68) of developing a renal stone. The renal stone risk was persistent (P=<0.0002, OR = 2.44, 95 % CI = 1.52-3.86) when analyzed for the synergistic effect of risk genotypes of SPP1 (CT) and UMOD (GG) gene. Further, correlation analysis also confirmed the strong association between genetic variants and renal stone development.Genetic variants of the SPP1 and UMOD genes were associated with renal stone disease. In the presence of risk genotype and hyperparathyroidism, hypercalciuria, and hyperoxaluria, the susceptibility to develop the renal stone disease risk gets modulated." @default.
• W4321073130 created "2023-02-17" @default.
• W4321073130 creator A5009640634 @default.
• W4321073130 creator A5018219292 @default.
• W4321073130 creator A5028090786 @default.
• W4321073130 creator A5039279462 @default.
• W4321073130 creator A5039924821 @default.
• W4321073130 creator A5066571530 @default.
• W4321073130 creator A5067431244 @default.
• W4321073130 creator A5076720717 @default.
• W4321073130 creator A5080217603 @default.
• W4321073130 creator A5082141392 @default.
• W4321073130 creator A5084232764 @default.
• W4321073130 date "2023-05-01" @default.
• W4321073130 modified "2023-10-03" @default.
• W4321073130 title "SPP1 and UMOD gene variants are synergistically associated with risk of renal stone disease" @default.
• W4321073130 cites W1926962235 @default.
• W4321073130 cites W1974745679 @default.
• W4321073130 cites W1984352965 @default.
• W4321073130 cites W2005129602 @default.
• W4321073130 cites W2011902550 @default.
• W4321073130 cites W2037647875 @default.
• W4321073130 cites W2038173227 @default.
• W4321073130 cites W2044410462 @default.
• W4321073130 cites W2045587732 @default.
• W4321073130 cites W2047376085 @default.
• W4321073130 cites W2054072985 @default.
• W4321073130 cites W2063771339 @default.
• W4321073130 cites W2067021754 @default.
• W4321073130 cites W2089035171 @default.
• W4321073130 cites W2089643587 @default.
• W4321073130 cites W2112341317 @default.
• W4321073130 cites W2144854963 @default.
• W4321073130 cites W2147737790 @default.
• W4321073130 cites W2151061868 @default.
• W4321073130 cites W2160570558 @default.
• W4321073130 cites W2181737729 @default.
• W4321073130 cites W2601713098 @default.
• W4321073130 cites W2618204419 @default.
• W4321073130 cites W2734654754 @default.
• W4321073130 cites W2786597035 @default.
• W4321073130 cites W2900802229 @default.
• W4321073130 cites W4241566092 @default.
• W4321073130 doi "https://doi.org/10.1016/j.gene.2023.147264" @default.
• W4321073130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36804854" @default.
• W4321073130 hasPublicationYear "2023" @default.
• W4321073130 type Work @default.
• W4321073130 citedByCount "1" @default.
• W4321073130 crossrefType "journal-article" @default.
• W4321073130 hasAuthorship W4321073130A5009640634 @default.
• W4321073130 hasAuthorship W4321073130A5018219292 @default.
• W4321073130 hasAuthorship W4321073130A5028090786 @default.
• W4321073130 hasAuthorship W4321073130A5039279462 @default.
• W4321073130 hasAuthorship W4321073130A5039924821 @default.
• W4321073130 hasAuthorship W4321073130A5066571530 @default.
• W4321073130 hasAuthorship W4321073130A5067431244 @default.
• W4321073130 hasAuthorship W4321073130A5076720717 @default.
• W4321073130 hasAuthorship W4321073130A5080217603 @default.
• W4321073130 hasAuthorship W4321073130A5082141392 @default.
• W4321073130 hasAuthorship W4321073130A5084232764 @default.
• W4321073130 hasConcept C104317684 @default.
• W4321073130 hasConcept C126322002 @default.
• W4321073130 hasConcept C134018914 @default.
• W4321073130 hasConcept C135763542 @default.
• W4321073130 hasConcept C2777724520 @default.
• W4321073130 hasConcept C2779728849 @default.
• W4321073130 hasConcept C2780306776 @default.
• W4321073130 hasConcept C31467283 @default.
• W4321073130 hasConcept C54355233 @default.
• W4321073130 hasConcept C71924100 @default.
• W4321073130 hasConcept C74460091 @default.
• W4321073130 hasConcept C77411442 @default.
• W4321073130 hasConcept C86803240 @default.
• W4321073130 hasConceptScore W4321073130C104317684 @default.
• W4321073130 hasConceptScore W4321073130C126322002 @default.
• W4321073130 hasConceptScore W4321073130C134018914 @default.
• W4321073130 hasConceptScore W4321073130C135763542 @default.
• W4321073130 hasConceptScore W4321073130C2777724520 @default.
• W4321073130 hasConceptScore W4321073130C2779728849 @default.
• W4321073130 hasConceptScore W4321073130C2780306776 @default.
• W4321073130 hasConceptScore W4321073130C31467283 @default.
• W4321073130 hasConceptScore W4321073130C54355233 @default.
• W4321073130 hasConceptScore W4321073130C71924100 @default.
• W4321073130 hasConceptScore W4321073130C74460091 @default.
• W4321073130 hasConceptScore W4321073130C77411442 @default.
• W4321073130 hasConceptScore W4321073130C86803240 @default.
• W4321073130 hasFunder F4320326160 @default.
• W4321073130 hasLocation W43210731301 @default.
• W4321073130 hasLocation W43210731302 @default.
• W4321073130 hasOpenAccess W4321073130 @default.
• W4321073130 hasPrimaryLocation W43210731301 @default.
• W4321073130 hasRelatedWork W1844518445 @default.
• W4321073130 hasRelatedWork W1966504330 @default.
• W4321073130 hasRelatedWork W1979139803 @default.
• W4321073130 hasRelatedWork W1988723255 @default.
• W4321073130 hasRelatedWork W2002987351 @default.
• W4321073130 hasRelatedWork W2020435820 @default.
• W4321073130 hasRelatedWork W2037631372 @default.

• next